hotspot -WSS

hotspot

author：knowledge 2025-10-01 17:30:09 - browse：424

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Mindstrong's demise and the future of mental health care

hotspot

WSS

Medicaid, Medicare dual

Shingles, which affected Dianne Feinstein, is on the rise

Microsoft's Peter Lee: Generative AI could help doctors be more human

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Harvard's David Sinclair gets blowback over aging

Immune cells and nerve overgrowth may explain recurring UTI pain

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Affirmative action in medical school literally saved lives

Cigna to pay $172 million to settle Medicare Advantage fraud probe

What does generative AI mean for health care? We asked experts

Ozempic has benefits for kidney disease as well as diabetes

The cancer drug shortage isn’t new — and neither are the solutions

Pregnant women don't need prenatal multivitamins, study concludes

Hepatitis C has a cure — but many Americans still lack access to it

Lack of health data on LGBTQ+ people has serious consequences

Jerome Adams on the need for new antivirals for Covid

WHO recommends dropping component of many flu vaccines

entertainment

For AI in health care standards, federal regulators join with industry group

Streamlined flu vaccines recommended by FDA advisory panel

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Florida health officials providing scant details on measles cases

Did you have Obamacare on your GOP debate bingo card?

Covid vaccines: Private market messier than government rollout

hotspot

hotspot

hotspot

knowledge